Medlive Technology Co., Ltd. (2192.HK) HKSE

9.22

-0.28(-2.95%)

Updated at December 10 11:59AM

Currency In HKD

Valuation

Market Cap6.86B
Enterprise Value3.04B
P/E Ratio18.94
PEG Ratio8.14
Price/Sales Ratio9.68
Price/Book Ratio1.27
Enterprise/Revenue5.01
Enterprise/EBITDA22.9

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.52
Operating Margin0.1

Management Effectiveness

Return On Assets0.06
Return On Equity0.07

Income Statement

Revenue558.46M
Revenue/Share0.85
Gross Profit327.22M
EBITDA121.35M
Net Income315.15M
Diluted EPS0.43

Balance Sheet

Total Cash3.62B
Total Cash/Share4.66
Total Debt14.97M
Total Debt/Equity0
Current Ratio20.65
Book Value Per Share6.61

Price History

52-Week Change-10.14
52-Week High17.18
52-Week Low8.39
Moving Average 50 Days10.84
Moving Average 200 Days13

Statistics

Average Volume2.29M
Shares Outstanding732.82M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield3.02
Payout Ratio0.58
Last Split FactorN/A
Last Split DateN/A